摘要
目的:观察左西孟旦对急性心肌梗死后心力衰竭的临床治疗效果。方法:选择本院80例急性心肌梗死后心力衰竭患者,根据治疗途径的差异将其划分为对照组和观察组,前者接受心梗后心衰常规治疗,后者在常规治疗的同时选择左西孟旦进行联合治疗,两组患者均接受综合护理。结果:接受治疗后,观察组的平均BNP指标为352.7±11.2pg/m L,明显低于与对照组的473.8±12.2pg/m L;观察组有效率明显高于对照组。结论:针对急性心肌梗死后心力衰竭患者,选择左西孟旦进行治疗能够取得良好效果。
Objective To observe the effect of levosimendan on the patients with acute myocardial infarction(AMI) complicated with heart failure(HF). Methods All the 80 patients with AMI and HF are randomly divided into observation group(40cases)and control group(40 cases). The tobservation group was treated with levosimendan. The control group was treated with dobutamine. Results After the treatment, the average BNP index of the observation group was 352.7 + 11.2pg/m L. Significantly lower than that of the control group of 473.8 + 12.2pg/m L. The effective rate of the observation group was significantly higher than that of the control group. Conclusion The treatment can achieve good results on patient with AMI and HF.
出处
《湖南师范大学学报(医学版)》
2016年第3期114-115,116,共3页
Journal of Hunan Normal University(Medical Sciences)